1. Home
  2. ZEUS vs ALLO Comparison

ZEUS vs ALLO Comparison

Compare ZEUS & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEUS
  • ALLO
  • Stock Information
  • Founded
  • ZEUS 1954
  • ALLO 2017
  • Country
  • ZEUS United States
  • ALLO United States
  • Employees
  • ZEUS N/A
  • ALLO N/A
  • Industry
  • ZEUS Metal Fabrications
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZEUS Industrials
  • ALLO Health Care
  • Exchange
  • ZEUS Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • ZEUS 406.7M
  • ALLO 431.9M
  • IPO Year
  • ZEUS 1994
  • ALLO 2018
  • Fundamental
  • Price
  • ZEUS $39.34
  • ALLO $2.07
  • Analyst Decision
  • ZEUS
  • ALLO Buy
  • Analyst Count
  • ZEUS 0
  • ALLO 12
  • Target Price
  • ZEUS N/A
  • ALLO $10.06
  • AVG Volume (30 Days)
  • ZEUS 107.1K
  • ALLO 2.5M
  • Earning Date
  • ZEUS 10-31-2024
  • ALLO 11-07-2024
  • Dividend Yield
  • ZEUS 1.57%
  • ALLO N/A
  • EPS Growth
  • ZEUS N/A
  • ALLO N/A
  • EPS
  • ZEUS 2.27
  • ALLO N/A
  • Revenue
  • ZEUS $2,012,296,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • ZEUS N/A
  • ALLO N/A
  • Revenue Next Year
  • ZEUS $5.62
  • ALLO N/A
  • P/E Ratio
  • ZEUS $16.80
  • ALLO N/A
  • Revenue Growth
  • ZEUS N/A
  • ALLO 26.47
  • 52 Week Low
  • ZEUS $32.23
  • ALLO $1.83
  • 52 Week High
  • ZEUS $73.49
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • ZEUS 40.83
  • ALLO 40.90
  • Support Level
  • ZEUS $40.52
  • ALLO $1.83
  • Resistance Level
  • ZEUS $42.98
  • ALLO $2.09
  • Average True Range (ATR)
  • ZEUS 1.34
  • ALLO 0.14
  • MACD
  • ZEUS -0.47
  • ALLO -0.01
  • Stochastic Oscillator
  • ZEUS 6.88
  • ALLO 30.92

About ZEUS Olympic Steel Inc.

Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: